Also thought i would share this if anyone is interested: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/considerations-development-chimeric-antigen-receptor-car-t-cell-products
FDA released the draft for considerations for the development of CAR T Cell Products. Good thing to base your due diligence on how biotechs are approaching their CAR-T Development. Not all of the information here will be disclosed publicly by these companies in detail (e.g. manufacturing details). But a lot of pre-clinical and clinical guidelines detailed in this report should give you an idea on whether CHM is in line with FDA requirements.
Also thought i would share this if anyone is interested:...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.5¢ | 0.4¢ | $11.72K | 2.783M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 2757364 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 15260220 | 25 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| CHM (ASX) Chart |